Skip to content
OpenCapital
Get started

Humacyte HUMA Q1 2026 earnings

Reported May 13, 2026 · Before market open

Revenue$495.0KMiss by $968.7K
EPS-$0.09Beat by $0.01
Revenue estimate$1.5M
EPS estimate-$0.10

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$1.1M
EPS estimate-$0.10

Versus estimates

Revenue

Q1 2026$495.0KMiss by $968.7K
Q4 2025$467.0KMiss by $882.3KQ3 2025$753.0KMiss by $596.0KQ2 2025$301.0KMiss by $616.8KQ1 2025$517.0KMiss by $247.8KQ4 2024$7.2MBeat by $6.6M

Diluted EPS

Q1 2026-$0.09Beat by $0.01
Q4 2025-$0.13In lineQ3 2025-$0.14Beat by $0.03Q2 2025-$0.24Miss by $0.09Q1 2025-$0.10Beat by $0.09Q4 2024-$0.16Beat by $0.07

Ask the moment Humacyte reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Humacyte report Q1 2026 earnings?
Humacyte (HUMA) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Humacyte's Q1 2026 revenue and EPS?
Humacyte reported revenue of $495.0K and eps of $-0.09 for Q1 2026.
Did Humacyte beat estimates in Q1 2026?
Revenue missed the consensus estimate of $1.5M by $968.7K. EPS beat the consensus estimate of $-0.10 by $0.01.
How did Humacyte's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.3% from $517.0K a year earlier and eps grew 10.0% from $-0.10.
Where can I find Humacyte's Q1 2026 SEC filings?
You can read the 10-Q periodic report (0001193125-26-221755) directly on SEC EDGAR. The filing index links above go to sec.gov.